Home / Insights / How to choose an oral dissolving film manufacturer
STRIPWORKS INSIGHTS

How to choose an oral dissolving film manufacturer

A buyer's checklist for vetting oral film manufacturers: formulation limits, pilot size, testing, batch records, packaging, and what a thin quote leaves out.

ANSWER IN BRIEF

Judge an oral film manufacturer on four things you can verify: the dose and dissolve limits they will put in writing, the size of the smallest run they will release with full testing, the documents they hand over per lot, and who supplies the sachets and cartons. Price only means something once those four are fixed.

What a complete oral film quote should state, and the weak answer to watch for
ItemWeak answerAnswer you want
Run size"10,000 strips"500 finished 20-count boxes; strips for testing and reserve samples listed separately
Strip spec"standard strip"Dimensions, dry thickness, finished weight, dissolve target
Finished-product testing"fully tested"Per lot or statistical subset (21 CFR 111.75(c)); tests named; lab named
Documents per lot"CoA available"Batch record per 21 CFR 111.260, CoA, reserve-sample log
Sachet"foil pouch"Laminate structure, foil gauge, seal type, WVTR
Cartons"included"Who prints, at what minimum, who holds surplus
Timeline"6 to 8 weeks"Duration per phase from feasibility to release

Ask for the whole path, not a capability list

The oral thin film market was about USD 3.3 billion in 2025 and is forecast to grow 9.35 percent a year through 2031 (Mordor Intelligence), so new suppliers keep appearing. Most brochures list the same nouns: formulation, pilot, packaging, testing. What separates them is the handoffs.

Ask the manufacturer to walk you from brief to reorder and put a duration on each stage. Ours are feasibility 3 to 5 business days, formula development 2 to 4 weeks, sample iteration 1 to 3 weeks, pilot 2 to 4 weeks, testing and release about a week. A supplier who cannot name its own phase timing has not run enough projects to know them.

Press on formulation limits

Vague promises about "any active" are the first warning sign. The film literature is specific: quick-release films are typically 2 to 8 cm2, 20 to 70 um thick, and carry the active at 5 to 30 percent of dry weight (Palezi et al., 2023), with polymer around 45 percent and up to 60 to 65 percent of the dry strip (Irfan et al., 2016). Every manufacturer works inside those physics.

Ask five questions and expect numbers back: What is your standard strip size? (Ours is 22 x 32 mm.) What dry film thickness and finished strip weight do you target? (50 to 150 um; 100 to 300 mg.) What is the largest single active you have taken to a released pilot? (Our development target is up to about 250 mg.) What dissolve time do you design to? (We use 30 to 60 seconds; FDA's orally disintegrating tablet guidance uses about 30 seconds as its benchmark.) How do you handle a bitter active?

Decision rule: if your active is under 25 mg and water-soluble, almost any competent film shop can make it. If it is above 100 mg, oil-based, or bitter, the answers to the questions above decide the project.

Find out what "testing" means

"Fully tested" covers a wide range. The regulation gives you the vocabulary. 21 CFR 111.70 requires written specifications for identity, purity, strength and composition and for contaminant limits. 21 CFR 111.75(c) allows finished-product testing on a statistically chosen subset of batches rather than every batch, so ask which one you are getting. 21 CFR 111.83 requires reserve samples of at least twice the full-test quantity, held in the retail package for one year past the shelf-life date.

Ask for a blank batch record and a sample certificate of analysis before you sign. 21 CFR 111.260 lists what a batch record must contain: lot number, equipment identity, component identifiers and weights, actual versus theoretical yield, in-process monitoring results, label reconciliation and the quality-control approval. If the sample record is a one-page checklist, the documentation will not hold up when a retailer or a lawyer asks for it.

Also ask who runs the tests. We apply standard release controls on every lot, send third-party testing through ILS Lab, and issue a Lot Release Packet per lot. A manufacturer that only tests in-house is not wrong, but you should know.

Remember that the regulatory burden stays with you

FDA's 2010 compliance guide is direct: a distributor that contracts out manufacturing and sells under its own label "has an obligation to know what and how manufacturing activities are performed" so it can decide whether to release the product. In practice that means assigning quality duties to the contractor in writing and making your own release decision on the documents it sends you.

Practically: choose a manufacturer whose documents you can actually read and act on, and keep your own copies. You also carry the label work. The Supplement Facts panel follows 21 CFR 101.36, any structure/function claim requires a 30-day notification under 21 CFR 101.93, and a novel ingredient needs the 75-day notification of 21 CFR 190.6. A good manufacturer will flag these; none of them will file for you.

Settle packaging responsibility

Ask who supplies the sachet laminate, who supplies cartons, who supplies dielines and artwork, and how unused printed components are counted and stored for the next run. Ask for the laminate structure and foil gauge in writing. We spec PET/aluminum/PE sachets against a 24-month shelf-life target; foil of at least 6 um is treated as an absolute barrier by the European Aluminium Foil Association, and a modest number of pinholes in thin foil has little effect on a laminate's moisture transmission (Sterilization Packaging Manufacturers Council). A supplier that cannot tell you the foil gauge cannot tell you the shelf life either.

Check carton minimums against production minimums. A 500-box pilot with a 5,000-carton print minimum means you will pay for cartons you may redesign after the pilot.

Score the quotes side by side

Worked example. Halden Labs wants a 25 mg L-theanine strip, 20-count, 500-box pilot. Two quotes arrive. Quote A lists a strip count and a total. Quote B lists 10,000 strips plus testing and reserve overage, names the sachet laminate and foil gauge, states whether finished-product testing is per lot or per subset, itemizes the certificates delivered, names who supplies cartons and at what minimum, and gives phase durations. Quote B can be compared with anything; Quote A cannot be compared with Quote B at all. Send Quote A back with the table below and ask for the missing rows.

The cheapest quote is often the one with the most assumptions left out, and each missing assumption becomes a change order.

Common questions

Should I ask a manufacturer for references?

Yes, but ask for a blank batch record and a sample certificate of analysis first. Those documents show the actual quality system; references show sales skill.

Is a manufacturer that tests every batch better than one that tests a subset?

21 CFR 111.75(c) permits either, provided the subset comes from a statistical sampling plan. For a first pilot, per-lot testing is simpler to explain to retailers. Ask which you are paying for.

Who is responsible if a contract-manufactured supplement fails?

FDA's compliance guide places the release decision and the obligation to know how the product was made on the own-label distributor. Contractors must comply with the parts of 21 CFR 111 that apply to the operations they perform.

Primary sources

Project-specific advice matters.

Formula feasibility, packaging, testing, claims, timing, and final quantities depend on the exact product. Use this guide to prepare better questions, then confirm the production plan for your project.

Bring the idea.
We’ll map the path.

Share your active ingredients, target dose, launch market and first-run volume. We’ll review the brief and identify the decisions needed for a pilot.

Review manufacturing capabilities · See project and quality controls

Send a project brief